Medidata Launches Global Education Program for Study Build and Study Management Professionals
Medidata has launched Rave EDC Certified Study Builder certification, a new offering in its global education program for study build and study management professionals. The Rave EDC Certified Study Builder Program offers a guided learning path to certification for new and existing Rave study builders, and includes core skills and applied skills assessments.
Study builders can expect a guided learning path, including:
- an instructor-led prep course to facilitate successful certification
- an abbreviated path enabling Classic Rave Certified Study Builders to upgrade their certification without the need to retake core Rave EDC training
Study Builders then complete an expanded core skills exam and applied skills assessment using a mock study build. Successful completion ends with a digital badge recognizing proficiency in Rave EDC study design and build, clinical view data settings, clinical view data review, and the use of Rave Reporter.
Reference
Global Medidata Certification Model Helps Rave EDC Study Builders Create New Value for Their Companies. (2023, March 23). Business Wire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
